This inventor holds 59 USPTO granted patents and 26 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Boron-Containing Molecules (CPC class A61K). Top assignees: Anacor Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd., Eli Lilly and Company. Active years: 1996-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Shizuoka-ken, JP (1996)
- Redwood City, CA (US) (2002 - 2004)
- Sunnyvale, CA (US) (2004 - 2023)
- Tokyo, JP (2023)
Company Filing History:
48 out of 70 
4 out of 730 
2 out of 4,514 
Years Active: 1996-2023
Areas of Expertise:
Title: Tsutomu Akama - Innovator in Pharmaceutical Chemistry
Introduction
Tsutomu Akama, based in Sunnyvale, CA, is a renowned inventor with an impressive portfolio of 59 patents. His contributions to the field of pharmaceutical chemistry have led to significant advancements in treatments for various diseases, particularly those relating to parasitic infections.
Latest Patents
Among his latest inventions are significant patents related to new chemical compounds. One of his notable patents is for "Oxaborole esters and uses thereof," which introduces oxaborole ester compounds that are effective in treating diseases such as Chagas Disease and African Animal Trypanosomosis. Another important patent focuses on "Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors," which relates to boron-containing compounds that inhibit phosphodiesterase 4 (PDE4), thus offering pharmaceutical compositions for various diseases that can benefit from this inhibition.
Career Highlights
Throughout his career, Tsutomu Akama has worked with esteemed organizations, including Anacor Pharmaceuticals, Inc. and Kyowa Hakko Kogyo Co., Ltd. His commitment to innovation in pharmaceutical chemistry has earned him recognition as a leading inventor in his field, contributing to the development of new therapies that address critical health challenges.
Collaborations
Tsutomu has collaborated with several talented individuals, including Jacob J. Plattner and Yong-Kang Zhang. These collaborations have facilitated the exchange of ideas and expertise, leading to groundbreaking inventions that enhance pharmaceutical research and development.
Conclusion
Tsutomu Akama's prolific contributions as an inventor highlight the importance of innovation in the pharmaceutical industry. His extensive patent portfolio reflects a dedication to finding solutions for diseases that impact millions globally. As he continues to forge new paths in research, his work promises to bring about transformative changes in the treatment of various diseases, underscoring the vital role of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile